This statistic shows the distribution of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phase of development. The share of cancer related ATMP trials in phase I and I/II was 24.2 percent.
Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phase
This statistic includes clinical trials from following databases: EudraCT (EU Drug Regulating Authorities Clinical Trials), ClinicalTrials.gov, and ICTRP (International Clinical Trials Registry Platform of the World Health Organization).
The table shows the number of ATMP trials in each disease area: cancer, cardiovascular diseases, immune system/inflammation,
musculoskeletal system, neurology, GI diseases and diabetes, ophthalmology, pulmonology, dermatology, haematology, and others. In
addition, it shows the percentage of ATMPs targeting every indication by phase of development.
* GI diseases: gastrointestinal diseases.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
JMAHP. (April 25, 2016). Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phase [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/828336/global-atmp-trials-classification-share-by-disease-and-development-phase/
JMAHP. "Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phase." Chart. April 25, 2016. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/828336/global-atmp-trials-classification-share-by-disease-and-development-phase/
JMAHP. (2016). Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phase. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/828336/global-atmp-trials-classification-share-by-disease-and-development-phase/
JMAHP. "Classification of Advanced Therapy Medicinal Product (Atmp) Trials Worldwide as of 2016, by Disease Area and Phase." Statista, Statista Inc., 25 Apr 2016, https://www-statista-com.ezproxy.canberra.edu.au/statistics/828336/global-atmp-trials-classification-share-by-disease-and-development-phase/
JMAHP, Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phase Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/828336/global-atmp-trials-classification-share-by-disease-and-development-phase/ (last visited November 10, 2024)
Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phase [Graph], JMAHP, April 25, 2016. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/828336/global-atmp-trials-classification-share-by-disease-and-development-phase/
